I hear some version of this question almost every clinic day. Someone walks in with months or years of joint or spine pain, a stack of MRI reports, and two very different recommendations. One doctor says, “You need surgery.” Another suggests platelet rich plasma or stem cells. The internet offers every opinion in between.
Sorting through this is not simple, but it is possible if you understand what regenerative medicine can and cannot do, and how surgeons and non‑surgical physicians think about the same problem from different angles.
This article walks through how experienced clinicians actually make that call. Along the way, I will address many of the questions that come up once you start reading about this field: what a regenerative medicine doctor is, where things stand with insurance, costs, success rates, and where surgery is still absolutely the better option.
What a regenerative medicine doctor actually does
In a clinical setting, regenerative medicine means using the body’s own biology to help repair, replace, or strengthen damaged tissues. Think less about “magic stem cells” and more about concentrated healing tools: platelets, growth factors, cells from your bone marrow or fat, and sometimes engineered scaffolds or biologic glues that support healing.
So, what is a regenerative medicine doctor?
Usually, it is not a separate specialty, but an additional focus layered on top of something else. For musculoskeletal problems, the physician typically trained first in:
- orthopedics sports medicine physical medicine and rehabilitation pain medicine sometimes rheumatology or interventional radiology
They then learn how to use orthobiologic treatments like platelet rich plasma (PRP), bone marrow concentrate, micro‑fragmented fat, or other cell‑based approaches, in combination with exercise, biomechanics, and sometimes traditional injections or medications.
In other areas, such as cardiology, dermatology, or endocrinology, doctors may use regenerative tools in organ or tissue specific ways, but the principle is similar: use biology to restore, not only to remove.
A good regenerative medicine doctor spends as much time ruling people out as ruling them in. That judgment is where the real expertise lies.
How regeneration works, in real biology, not just marketing
Before talking about candidacy, it helps to anchor the word “regeneration” in something real.
Classical biology describes four types of regeneration in living organisms:
Epimorphosis: regrowth from a mass of cells, as when a salamander regrows a limb. Morphallaxis: reorganization of existing tissue, seen in simple organisms like hydra. Compensatory regeneration: remaining cells enlarge or multiply to compensate, like the way the liver can regrow after partial removal. Tissue specific renewal: constant low level repair, such as skin and gut lining cells turning over regularly.Human regenerative medicine borrows from these principles but works within our limits. We are not salamanders; we will not regrow a knee. What we can sometimes do is:
- improve the health and thickness of cartilage at the damaged margins strengthen supporting ligaments and tendons improve the internal environment of a joint so it hurts less and functions better slow or occasionally reverse early structural changes
That means regenerative medicine often shines for partial damage, early to moderate arthritis, or chronic soft tissue injury. Once a structure is fully destroyed or grossly unstable, you are usually outside the realistic scope of what biologic repair can offer.
When surgery is clearly the first choice
Even as someone who uses regenerative tools, I refer people to surgeons frequently. There are scenarios where biology alone will not fix the problem you have.
Surgery is often the better first choice when:
- A structure is completely torn with loss of function, such as a full thickness quadriceps tendon tear that prevents you from extending the knee. A joint is grossly unstable, as in certain severe ligament injuries, dislocations, or fractures involving the joint surface. There is significant mechanical obstruction, such as a large loose body or severe spinal canal narrowing that creates progressive neurologic deficits. A joint is at the “bone on bone” end stage with major deformity and night pain that affects every step, and conservative treatments have repeatedly failed.
In these situations, asking PRP or stem cells to “regrow” what is missing is unfair to the treatment and to you. When the physical architecture is too far gone, you may need a surgeon to rebuild or replace the structure first.
This is one of the biggest problems with regenerative medicine in current practice: overselling what it can do for very advanced disease. The science supports meaningful improvement in the right cases, but not miracles in joints that are already beyond salvage.
Who is a good candidate for regenerative medicine?
Despite all the nuance, there are common patterns that point toward good candidacy. I have found the following features often overlap in people who respond well.
You are more likely to be a good candidate for regenerative medicine if:
- Your problem is structural but not end stage: partial tendon tears, early to moderate arthritis, focal cartilage damage, chronic ligament sprain, or disc related pain without severe nerve compression. Your imaging shows damage that matches your symptoms, yet surgeons are hesitant to operate or suggest you are “not bad enough” for a major procedure. You have meaningful function to preserve: you want to stay active in a physical job, athletics, or simply independent daily life, and you are motivated to follow a rehabilitation plan. You have tried standard conservative care such as physical therapy, activity modification, and possibly cortisone, and either plateaued or had only short lived benefit. You understand that success is measured in less pain and better function, not perfection or joint regrowth on MRI.
Age alone is not an absolute cutoff. I have seen people in their seventies do well with PRP for knee arthritis and younger patients in their thirties with such advanced damage that even aggressive biologics made little difference.
Health status matters more: uncontrolled diabetes, heavy smoking, active cancer, or severe autoimmune disease can impair healing. Medications like high dose steroids and some immune suppressants can also reduce the effectiveness of regenerative procedures.
If the physician does not ask detailed questions about your overall health, medications, sleep, nutrition, and activity, they are missing important parts of the candidacy picture.
When you are on the fence between surgery and regenerative care
Many people live in the gray zone, where neither option is clearly right or wrong. This is where a careful exam and imaging review become critical.
Good clinicians spend time on three questions.
First, is there a clear mechanical problem that only surgery can fix, or is the main issue pain and function in a joint that still has usable structure? For example, a meniscus tear in the knee can be a red flag or a red herring. A large displaced tear that locks the knee is different from a small degenerative tear in a 55 year old that many people walk around with without symptoms.
Second, how urgent is the situation? Progressive weakness, dropping objects, loss of bowel or bladder control, or true giving way of a joint point toward surgical urgency. Chronic, predictable pain with standing, walking, or sport usually allows more time to explore regenerative options.
Third, what is the patient’s risk tolerance and life context? A professional carpenter with a shoulder tear and overhead demands thinks differently than a retiree who golfs twice a week. Someone caring for a spouse or young children may have limited ability to take months off for surgical recovery.
In borderline cases, I often recommend a staged strategy. Try a targeted regenerative treatment with a clear timeframe for reassessment, usually three to six months. If function and pain improve to an acceptable level, you may delay or even avoid surgery. If not, you have still not lost your surgical option.
How painful is regenerative medicine?
People often ask, “Is regenerative medicine painful?” The honest answer is that it depends on the specific procedure, the body area, and how it is performed.
Simple PRP injections into a joint can be mildly to moderately uncomfortable, similar to a cortisone shot but with more ache in the following days. Tendon or ligament treatments, especially when the tissue is stimulated with small needles to trigger healing, can be more intense during and shortly after the procedure.
Bone marrow aspiration to obtain cells from your pelvis is usually done with local anesthesia and sometimes light sedation. Most describe it as pressure and a few sharp moments rather than severe pain, with soreness for a couple of days.
A skillful physician uses imaging guidance, local numbing, and procedure planning to reduce discomfort. For most patients, the short term pain is manageable, and serious complications are rare when done in an appropriate setting by experienced hands.
If a clinic markets “stem cell miracles” but glosses over the details of the actual procedure, that is a sign to slow down and ask more questions.
What is the success rate of regenerative medicine?
There is no single success rate, because regenerative medicine is a broad umbrella. PRP for tennis elbow, bone marrow concentrate for early hip arthritis, and fat derived cell injections for degenerative discs are very different animals.
A more honest way to think about it is by condition and treatment type.
For orthopedic problems:
- PRP for chronic tennis elbow and some tendonitis conditions shows success rates, defined as significant pain reduction and functional improvement, often in the 70 to 85 percent range in published studies. PRP for knee osteoarthritis tends to show better and longer lasting results than hyaluronic acid injections in many trials, with meaningful relief in a majority of patients, especially in early to moderate disease. Bone marrow concentrate or similar cell based treatments for joints have smaller but growing evidence, with many case series and some controlled studies suggesting benefit, but results are more variable, and protocols differ widely.
Success also depends on definitions. Some patients want to return to running marathons; others simply want to climb stairs without pain. A good physician spells out realistic goals for your specific situation, rather than offering a generic success rate.
If anyone quotes a very precise percentage for your personal case without referencing condition specific data or explaining uncertainty, be cautious.
The biggest problems and disadvantages of regenerative medicine
The science is promising, but the field has some real issues that affect patients trying to make decisions.
What is the biggest problem with regenerative medicine today? From my perspective, it is the combination of uneven evidence, uneven training, and aggressive marketing.
Some of the key disadvantages and challenges include:
- Regulatory gray zones: In many countries, especially for “stem cell therapy”, regulations lag behind marketing. Clinics sometimes offer unproven cell treatments harvested and processed in ways that exceed what regulators allow, or ship patients overseas to sidestep oversight. Variable training: There is no single accredited “regenerative medicine” residency. You can find board certified orthopedic surgeons doing careful PRP work, and weekend‑trained providers offering the same procedures in a spa setting. Patients often cannot tell the difference. Cost and access: Most of these treatments are paid out of pocket, which amplifies socioeconomic disparities and invites sales tactics more common to retail than to medicine. Hype outpacing data: Some applications have strong supporting evidence. Others, particularly systemic stem cell infusions for many internal conditions, remain experimental. Yet they are marketed with certainty that the science does not justify. Unmet expectations: Because the word “regeneration” sounds like regrowth, some patients expect imaging proof that tissue has been rebuilt. In reality, much of the benefit seems to come from modulating inflammation and strengthening existing tissue, not regrowing whole structures.
These problems do not mean the field lacks value. It means you need to choose your clinician carefully and understand what you are paying for.
Costs, insurance, and the money questions
Two of the most common questions are: Will insurance pay for regenerative medicine, and what is the average cost of regenerative medicine?
In the United States, most insurers still consider many regenerative treatments experimental or not medically necessary, especially when labeled as “stem cell therapy.” PRP is increasingly accepted in some specific situations, such as certain tendinopathies, but coverage is patchy.
For many orthobiologic treatments:
- PRP injections often range from roughly 500 to 2,000 dollars per session, depending on geographic region, equipment used, and the joint or area treated. Bone marrow concentrate or fat based cell procedures are usually more, often in the 3,000 to 8,000 dollar range per treatment region, sometimes higher for multi‑joint or staged procedures. Package deals or “full body stem cell makeovers” with eye‑popping prices should raise questions about clinical necessity and evidence.
“Does insurance cover Kinetix?” is a version of this I hear regarding specific branded products or protocols. In most cases, if Kinetix is a proprietary regenerative injection or blood product, standard health insurance does not cover it, though workers’ compensation or certain progressive plans may make rare exceptions. You need to check directly with both the clinic and your insurer, and get preauthorization in writing if coverage is claimed.
On the physician side, people sometimes ask, “How much do regenerative medicine doctors make?” and even, “Who is the highest paid doctor specialty, and what is the lowest paying doctor specialty?” It is useful context, but not the main factor in choosing your care.
In general survey data, orthopedic surgeons, plastic surgeons, cardiologists, and some neurosurgeons tend to sit at the top of the income spectrum. Primary care specialties like pediatrics and family medicine are often among the lowest paid. Regenerative medicine doctors are not one group; their earnings depend on their base Regenerative Medicine Doctor specialty, practice model, and how much of their work is cash based. A busy orthopedic or sports medicine physician offering regenerative procedures may earn more than a colleague who relies only on insurance reimbursement, but that reflects the overall economics of fee for service medicine, not automatically a sign of greed or virtue.
When you sit in front of a physician, you are not looking at national averages. You are evaluating whether they are recommending a treatment for you, in your context, with transparent reasoning.
Stem cell tourism, Joe Rogan, and “best countries” for treatment
Any search about regenerative medicine quickly leads to stories of celebrities traveling overseas for stem cells. One high profile example is Joe Rogan, who has spoken publicly about receiving stem cell treatment in Panama. That care has often been linked to clinics using high dose mesenchymal stem cell infusions, typically derived from umbilical cord tissue, for various orthopedic and systemic complaints.
This leads to questions like, “What country is best for stem cell treatment?”
The honest answer is that “best” depends on what you value: regulatory oversight, evidence based practice, or access to more speculative treatments.
Countries like the United States, many in the European Union, and some in East Asia tend to have stricter regulations on cell manipulation and require evidence for approved indications. The upside is better safety oversight and more standardized practices. The downside is that some treatments that might be promising but not yet fully proven are not widely available outside of clinical trials.
Countries such as Panama, Mexico, and certain others in Latin America and Asia have become hubs for stem cell tourism precisely because they allow more liberal use of cell therapies. Some clinics there are run by serious scientists and physicians trying to push the field forward. Others are essentially businesses offering expensive, unproven infusions with limited follow up.
If you are considering leaving your home country for treatment, you should absolutely review the scientific basis of what they propose, ask about cell sourcing and processing, and insist on clear safety and outcome data. The mere fact that a celebrity visited a clinic is not meaningful evidence.
Fasting, cell regeneration, and whole body health
Interest in regeneration sometimes spills into lifestyle questions such as, “Does fasting for 72 hours regenerate cells?” The short version: prolonged fasting and certain forms of intermittent fasting appear to stimulate cellular repair pathways and autophagy in animal models, and early human studies suggest potential benefits in metabolic health and possibly immune system resetting.
However, three days of fasting is not going to regrow a worn cartilage surface in your knee. Systemic cellular housekeeping processes are real, but they operate at a different level than targeted tissue repair after years of mechanical wear or specific injury.
For joint and tendon problems, nutrition, sleep, and metabolic health still matter. People with well controlled blood sugar, adequate protein intake, and good overall conditioning tend to heal better from both surgery and regenerative procedures. If you are considering aggressive fasting, especially if you have medical conditions, it should be done in consultation with a clinician Regenerative Medicine Doctor who knows your history, not as a replacement for evidence based treatment.
A practical checklist before you commit
When patients are deciding between surgery and regenerative care, I often walk them through a simple internal checklist. It helps separate emotion from facts.
Here are key questions to ask yourself and your doctor:
- Has the surgeon clearly explained what will be fixed, how, and what the realistic recovery timeline and risks are, including the chance that pain might persist? Has the regenerative medicine physician examined you personally, reviewed your imaging, and explained which tissues they are targeting, with what evidence for your specific condition? Are you clear on the total cost, number of treatments, and what outcome would count as “success” for you in daily life? Do you have nonnegotiable time constraints, such as work, family care, or athletic seasons, that favor one path over another? Have you obtained at least one second opinion, especially if anyone, surgical or regenerative, seems to promise guaranteed outcomes?
Writing your answers down and discussing them with someone who knows you well often clarifies the path more than another hour of internet searches.
Red flags when considering regenerative clinics
Because the field has grown so fast, it is worth naming specific warning signs that should prompt caution or a second opinion.
Watch for:
- Vague claims about “stem cell therapy” without specifying whether cells are actually being harvested from you, how they are processed, or what regulatory framework they fall under. One size fits all protocols that look identical whether the issue is knee arthritis, back pain, or an autoimmune disease, especially if they rely on intravenous infusions for everything. High pressure sales tactics, limited time discounts, or financing offers that feel more like buying a timeshare than receiving medical care. Lack of interest in your comprehensive medical history, medications, and functional goals, and a focus only on selling a package. Reluctance to discuss published evidence, realistic success rates, or what happens if the treatment does not help.
Good clinicians welcome your questions, acknowledge uncertainty, and respect your right to take time before committing.
Bringing it all together
When you strip away the marketing language and online debates, the decision between regenerative medicine and surgery comes down to a few grounded truths.
First, structure matters. If a joint or tendon is mechanically beyond repair, you likely need a surgeon. If there is meaningful but incomplete damage, biologic repair often has a role, sometimes as an alternative, sometimes as a bridge or complement to surgery.
Second, timing matters. Chronic, stable pain allows for a trial of regenerative care far more than rapidly progressive weakness or neurologic compromise.
Third, expectations matter. Regenerative medicine at its best helps you hurt less, move more, and delay or avoid more invasive procedures. It does not turn a 65 year old knee into a 20 year old knee.
Finally, people matter. The experience, ethics, and judgment of the physician in front of you often matter more than the brand name of the treatment. Whether you choose surgery, regenerative care, or a combination of both, you deserve a clear explanation of why, what the evidence says, and how success will be measured in your real life, not only in an advertisement or on a scan.
If you keep those principles in sight, the question “Am I a good candidate for regenerative medicine or do I need surgery?” becomes less of a mystery and more of a structured, collaborative decision.